Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study. #HeartFailure2024 #HFA_ESC

Excitement are building up on the first day of #HeartFailure2024! Met @ARuwald who came all the way from Copenhagen, Denmark for the congress 😊 #HFAmotions #HFA_ESC @escardio

Congratulations to all the investigators👏 @CHassager @MGLindholm @joyland2704 @LHolmvang

Last talking points this year. Presenting on-going research activities at the department. First up, @ARuwald with the department’s participation in the nationwide DANABLATE-HF trial. #dkforsk

Vil du høre eksperternes mening om ablation for atrieflimren? 🫀 Fredag d. 15/3 fra kl. 15-16 afholdes et virtuelt symposium med Professor @chris_sohns fra Bad Oeynhausen, Tyskland om ablation og CASTLE-HTX-studiet‼️ Tilmeld dig her:

🗓️ Mark the calendars! 🗓️ Next weekend, we host our annual Weekend of Research as a celebration of our research activities! Also, the topic of this year's discussion is atrial fibrillation with @chris_sohns, @Dominik_Linz, and @Jacob_M_Larsen as some of our guest speakers!

ARIES-HM3 Trial: In patients with HF receiving HM3 LVAD, VKA alone without aspirin results in no change in thrombotic outcomes, significantly less bleeding and less hospitalizations. Download slides for the ARIES-HM3 trial on excluding aspirin in LVAD HM3 presented at #AHA23

Many relevant findings from PhD student @kasperbengtsen in his national study on risk factors associated with early and late S. aureus bacteraemia in CIED pts presented at #ESCCongress 🫀🧫 Congratulations on the hard work!👏👏 #ESC2023 #DCS_ESC23

Danish data show higher CV risk in individuals with initial remission of #T2D than in those with well-controlled T2D on glucose-lowering therapy. This appeared related to lower CV RF management with statins and RASi. @AFalkentoft @ARuwald @Filip_Knop https://t.co/j5wPhLtNZX 🔓

Congratulations on a very well deserve PhD title @AFalkentoft You did great💪 @mortschou @NielsEskeBruun @CardiologyZuh

Awaiting the PhD defence of @AFalkentoft - Good luck😊 @CardiologyZuh

Which trials have been the most interesting/groundbreaking at #HeartFailure2023 ?

The word “Pragmatic” is echoing throughout #HeartFailure2023 . This is a great development - we need more trials were the results are applicable in real-life HF population @drjohnm @TorBiering @CardiologyZuh

📢 Calling all young cardiologists of the #HFAYoung community! Join us for the annual group photo at #HeartFailure2023, in Prague! 🗓️: 21 May 2023 ⌚️: 12:30 📍: HFA stage @SotiriaLiori @_antocannata @HanCardiomd @h_arfsten @jozinetm @M_Sokolski @HFA_President

Go listen to prof. Gustafsson from the department of cardiology at @Rigshospitalet talk about advanced heart failure and optimal treatment modalities 🫀💊 #RigsHeart

Great achievement 🏆 ⁦⁦@MRuwald⁩ ⁦@CopCard⁩ defends his doctoral dissertation 📜 ⁦@koebenhavns_uni⁩ ⁦@HerlevGentofte⁩

Excited to hear @MRuwald doctoral dissertation 👏 @CopGAG

Dr. @ARuwald (@CardiologyZuh) on #STRONG-HF-trial: Fast vs normal uptitrate of #GDMT. @SLKristensen @FinnGustafsson #DCS_HF2023 @Pallisgaard_MD @kr_johanna

Status on 119 pulsed field ablations for #afib @HGHHjerte ✴️Procedure time reduction from 85 to 72 min ✴️Fluoroscopy time reduction from 22 to 16min ✴️AFib Event-free at 365 days 88% for paroxysmal vs 69% for persistent @MRuwald et al in @JICE_EP https://t.co/FaGddwAwCB

🫵Præsenter din forskning ved DCS Årsmøde 2023🫵 4️⃣ kategorier 👉 DCS Foredragskonkurrence for yngre kardiologer 👉 Oral præs: original forskning 👉 Poster præs: ny forskning 👉 Poster præs: forsvaret afhandling 🗓️ Deadline er 21. februar 2023 kl. 12:00 https://t.co/deY2LdAS8H